Year archive

Zhaoke Ophthalmology Limited — 2023 filings

All 38 regulatory filings released by Zhaoke Ophthalmology Limited (6622) in 2023, sourced directly from the official regulator.

38 Filings

2023 Period

2023 filings (38)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2023 Regulatory Filings	2023-12-01	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2023-11-27	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE Board/Management Information	2023-11-27	English
(1) CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EYPROTOR AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER CMO SERVICE AGREEMENT M&A Activity	2023-11-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2023 Regulatory Filings	2023-11-02	English
VOLUNTARY ANNOUNCEMENT - POSITIVE TOP-LINE RESULTS FROM NVK002 ONE-YEAR PHASE III CLINICAL TRIAL (MINI-CHAMP) IN CHINA FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN Capital/Financing Update	2023-10-13	English
VOLUNTARY ANNOUNCEMENT - UPDATES ON PHASE III CLINICAL TRIALS FOR TAB014 AND EPINASTINE HCl AND UPDATE ON THE NEW DRUG APPLICATION FOR CYCLOSPORINE A (CsA) OPHTHALMIC GEL Capital/Financing Update	2023-10-03	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2023 Regulatory Filings	2023-10-03	English
2023 Interim Report Regulatory Filings	2023-09-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2023 Regulatory Filings	2023-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report H1 2023	2023-08-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-08-11	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF NVK002 PHASE III MINI-CHAMP LAST PATIENT LAST VISIT IN CHINA Regulatory Filings	2023-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2023 Regulatory Filings	2023-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2023 Regulatory Filings	2023-07-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2023 Regulatory Filings	2023-07-03	English
Voluntary Announcement - U.S. FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR NVK002 FOR TREATMENT OF MYOPIA PROGRESSION Regulatory Filings	2023-06-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2023 Regulatory Filings	2023-06-02	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 25, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-05-25	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2023 Regulatory Filings	2023-05-02	English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REQUEST FORM Report Publication Announcement	2023-04-27	English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM Report Publication Announcement	2023-04-27	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, MAY 25, 2023 AGM Information	2023-04-27	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2023-04-27	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND AGM Information	2023-04-27	English
Environmental, Social and Governance Report 2022 Regulatory Filings	2023-04-27	English
2022 Annual Report Annual Report FY 2022	2023-04-27	English
Voluntary Announcement - POSITIVE TOP-LINE DATA FROM PHASE 3 PIVOTAL BRIO-I TRIAL OF BRIMOCHOL PF FOR THE TREATMENT OF PRESBYOPIA Capital/Financing Update	2023-04-25	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2023 Regulatory Filings	2023-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report FY 2022	2023-03-27	English
Voluntary Announcement - ENTERING INTO DISTRIBUTION AGREEMENT WITH KWANGDONG PHARMACEUTICAL TO COMMERCIALIZE NVK002 IN SOUTH KOREA Regulatory Filings	2023-03-27	English
Voluntary Announcement - NO BANK ACCOUNT IN SILICON VALLEY BANK OR ITS AFFILIATES Regulatory Filings	2023-03-13	English
NOTICE OF BOARD MEETING Report Publication Announcement	2023-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2023 Regulatory Filings	2023-03-02	English
INSIDE INFORMATION - MARKETING AUTHORIZATION FOR BIMATOPROST TIMOLOL EYE DROP (JINGBEIYING) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-02-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-01	English
Voluntary Announcement - CYCLOSPORINE A (CsA) OPHTHALMIC GEL PASSED THE ON-SITE REGULATORY AND CLINICAL TRIAL INSPECTIONS BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION AND THE GMP COMPLIANCE INSPECT Regulatory Filings	2023-01-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-04	English